The CAP Foundation welcomes new institutions to apply for See, Test & Treat® program grants. See, Test & Treat provides free breast and cervical cancer screening to underserved women.

The CAP supports the use of individual risk-based questions instead of gender-based criteria to evaluate donors for risk of HIV and encourage the FDA to continue monitoring blood donor and donation safety.

For Pride Month, the College of American Pathologists and its members are working to demystify and dismantle misconceptions around stem cell donation from those in the LGBTQ population.

The module, Screening and Diagnosis of Hepatitis B Virus (HBV) Infection can help reduce diagnostic errors and positively impact the disparity of HBV in the Asian American and Pacific Islander community.

The CAP was invited by Rep. Robin Kelly (D-IL), co-chair of the Congressional Black Caucus (CBC) Health Braintrust, to discuss the CAP's top health equity and disparities priorities for the 118th Congress.

This article highlights the CAP's efforts to promote and advance diversity in clinical trials, a critical area of medicine that often fails to represent and serve minorities.

The recent decline in breast cancer mortality rates around the world is attributed to an increase in patient education, advances in breast imaging and screening and breast cancer therapy innovations. Despite all the advances made, early breast cancer detection, treatment and control have not equally benefitted all patient populations. Breast cancer patients who are African American suffer from a higher mortality rate compared to their white counterparts in the United States.

CAP has developed recommendations to aid adoption of the newly developed 2021 CKD-EPI-creatine equation for estimated glomerular filtration rate (eGFR). The new equation eliminates race-based adjustment factors that can delay recognition of chronic kidney disease (CKD), especially in Black/African American individuals.